Literature DB >> 8065258

The 24 kDa N-terminal sub-domain of the DNA gyrase B protein binds coumarin drugs.

E J Gilbert1, A Maxwell.   

Abstract

A number of lines of evidence suggest that the N-terminal sub-domain of the DNA gyrase B protein contains the binding site for the coumarin antibiotics. We have engineered a clone which encodes a 24 kDa protein which represents this domain. Bacteria which overproduce this protein show an elevated level of resistance to coumarins, suggestive of binding of the 24 kDa protein to the drugs in vivo. In vitro we find that the 24 kDa protein does not interact with the gyrase A or B proteins or with DNA, and fails to hydrolyse ATP or show significant binding to ATP, ADP or ADPNP. However, we show that the 24 kDa protein binds coumarin drugs as tightly as the intact B protein. A number of experiments suggest that the interaction of the coumarins with the protein is predominantly hydrophobic in nature.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8065258     DOI: 10.1111/j.1365-2958.1994.tb01026.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  15 in total

1.  Potentiation of Helicobacter pylori CagA protein virulence through homodimerization.

Authors:  Lisa Nagase; Naoko Murata-Kamiya; Masanori Hatakeyama
Journal:  J Biol Chem       Date:  2011-08-03       Impact factor: 5.157

2.  Mode of action of GR122222X, a novel inhibitor of bacterial DNA gyrase.

Authors:  M Oram; B Dosanjh; N A Gormley; C V Smith; L M Fisher; A Maxwell; K Duncan
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

3.  GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin.

Authors:  M Stieger; P Angehrn; B Wohlgensinger; H Gmünder
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

4.  Probing the role of the ATP-operated clamp in the strand-passage reaction of DNA gyrase.

Authors:  A P Tingey; A Maxwell
Journal:  Nucleic Acids Res       Date:  1996-12-15       Impact factor: 16.971

5.  Modulation of gyrase-mediated DNA cleavage and cell killing by ATP.

Authors:  T K Li; L F Liu
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

Review 6.  Topoisomerases as anticancer targets.

Authors:  Justine L Delgado; Chao-Ming Hsieh; Nei-Li Chan; Hiroshi Hiasa
Journal:  Biochem J       Date:  2018-01-23       Impact factor: 3.857

7.  Silencing of glycopeptide resistance in Enterococcus faecalis BM4405 by novobiocin.

Authors:  Lorena Abadía Patiño; Marc Chippaux; Patrice Courvalin; Bruno Périchon
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

8.  Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and coumarin activity.

Authors:  B Fournier; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

9.  The ectodomain of the Toll-like receptor 4 prevents constitutive receptor activation.

Authors:  Gabriela Panter; Roman Jerala
Journal:  J Biol Chem       Date:  2011-05-04       Impact factor: 5.157

10.  Ser-127-to-Leu substitution in the DNA gyrase B subunit of Streptococcus pneumoniae is implicated in novobiocin resistance.

Authors:  R Muñoz; M Bustamante; A G de la Campa
Journal:  J Bacteriol       Date:  1995-07       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.